Gold has continued to hit record highs despite several headwinds and UBS expects the price to see a pullback in the near term and then rally to further new records later in the year.  The Swiss bank sees gold being supported by several trends. These include the US Federal Reserve "appearing on track" to cut interest rates, support for gold from central banks and investors buying gold, and heightened geopolitical risk. “We remain positive on the price of gold for 2024, and continue to recommend it as a portf ...

The world’s largest semiconductor foundry, Taiwan Semiconductor Manufacturing Company (TSMC for short) has a client portfolio of two halves. Cornerstone client Apple Inc (NASDAQ:AAPL, ETR:APC), though it remains the world’s second most valuable company, has experienced a rough patch of late, with iPhone sales plummeting in the important Chinese market. This presents a problem for TSMC, which generates a significant portion of its revenues by manufacturing the chips that go into Apple iPhones. But TSMC has f ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Novo Nordisk (NYSE:NVO)'s shares are significantly overvalued, based on analysis shared by the American bank Jefferies in a note to clients. It said that, as ever, Novo delivered its 'usual polished performance' at its capital markets day earlier this week, but added "we struggle to justify the stock uptick". Year-to-date, the shares are up by a third, while the past five years have seen the company's valuation grow by more than 400% on the back of the success of its diabetes-turned-weight loss drugs. Today ...

Boeing Co (NYSE:BA, ETR:BCO) is under the regulatory spotlight once again after a Japan-bound United Airlines 777 was forced to divert on Thursday, having lost a tire after taking off in San Francisco. Flight UAL35 safely landed at Los Angeles following the incident, having been due to head to Kansai International Airport near Osaka, Japan. America’s Federal Aviation Authority has since confirmed it has launched an investigation, with Boeing already facing heavy scrutiny after a door panel fell from one of ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

Goldman Sachs Group Inc (NYSE:GS, ETR:GOS) forecasts that US share buybacks will surpass $1 trillion for the first time in 2025. The Wall Street institution said this remarkable number is influenced by robust earnings growth from technology companies and more relaxed financial conditions anticipated from pending Federal Reserve interest rate cuts. Goldmans predicts a 16% increase in share repurchases among S&P 500 companies, reaching $1.08 trillion in 2025, following a 13% rise to $925 billion in the curren ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

Novo Nordisk (NYSE:NVO) unveiled a potential game changer during its Capital Markets Day with data on experimental obesity pill amycredtin potentially outperforming its blockbuster drug Wegovy. An early-stage test conducted over 12 weeks showed patients taking the pill lost 13% of their weight. Though trials are still in their early stages, Novo Nordisk (NYSE:NVO) hopes it can add another killer app to its portfolio of weight-loss drugs. The successes of Wegovy and Novo Nordisk’s other injection-based obesi ...